Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
Mucopolysaccharidosis type I (MPS I) is the hereditary disease characterized with alpha-L-iduronidase activity decrease and further accumulation of heparan and dermatan sulfate in lysosomes. MPS I is rare autosomal recessive disorder with incidence of 0.5–4 cases on 100.000 live-birth infants. Meant...
Saved in:
Main Authors: | Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Natalia V. Zhurkova, Ekaterina Yu. Zakharova, Svetlana V. Mikhaylova, Grigory V. Revunenkov |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2019-09-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
by: Nato V. Vashakmadze, et al.
Published: (2023-12-01) -
Differential Diagnosis of Hurler and Hurler–Scheie Syndromes: Clinical Case
by: Nataliya V. Buchinskaya, et al.
Published: (2025-05-01) -
Mucopolysaccharidosis Type I (Hurler – Scheie Syndrome): Case Report
by: Nato D. Vashakmadze, et al.
Published: (2024-09-01) -
Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01) -
Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)